These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 7684823
1. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, Endo Y, Nagataki S. N Engl J Med; 1993 Jun 24; 328(25):1802-6. PubMed ID: 7684823 [Abstract] [Full Text] [Related]
2. A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients. Shiraki K, Takase K, Tameda Y, Hamada M, Kosaka Y, Nakano T. Hepatology; 1995 Sep 24; 22(3):802-7. PubMed ID: 7544756 [Abstract] [Full Text] [Related]
3. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Taketa K, Endo Y, Sekiya C, Tanikawa K, Koji T, Taga H, Satomura S, Matsuura S, Kawai T, Hirai H. Cancer Res; 1993 Nov 15; 53(22):5419-23. PubMed ID: 7693340 [Abstract] [Full Text] [Related]
4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ. J Gastroenterol Hepatol; 2008 Oct 15; 23(10):1541-8. PubMed ID: 18422961 [Abstract] [Full Text] [Related]
5. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease. Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H. Oncol Rep; 2011 Nov 15; 26(5):1227-33. PubMed ID: 21874252 [Abstract] [Full Text] [Related]
6. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis. Kuwahara T, Sakai T, Majima Y, Hirai K, Tanikawa K. Hepatogastroenterology; 1993 Aug 15; 40(4):347-51. PubMed ID: 7691701 [Abstract] [Full Text] [Related]
7. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis. Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T. Int J Mol Med; 2002 Mar 15; 9(3):245-50. PubMed ID: 11836630 [Abstract] [Full Text] [Related]
8. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R. Am J Gastroenterol; 2000 Apr 15; 95(4):1036-40. PubMed ID: 10763956 [Abstract] [Full Text] [Related]
9. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH. Clin Cancer Res; 2008 Jan 15; 14(2):470-7. PubMed ID: 18223221 [Abstract] [Full Text] [Related]
10. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma]. Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL. Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741 [Abstract] [Full Text] [Related]
11. Fucosylation index of alpha-fetoprotein, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis. Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, Mori S, Suda T, Isemura M, Asakura H. Hepatology; 1993 Jan 22; 17(1):50-2. PubMed ID: 7678576 [Abstract] [Full Text] [Related]
12. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M. Clin Gastroenterol Hepatol; 2009 Jan 22; 7(1):104-13. PubMed ID: 18849011 [Abstract] [Full Text] [Related]
13. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL. Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, Satomura S. Cancer Sci; 2011 May 22; 102(5):1025-31. PubMed ID: 21244578 [Abstract] [Full Text] [Related]
14. [Early detection of hepatocellular carcinoma with lectin reactive alpha-fetoprotein]. Matsuyama H, Morishita Y, Nakane K, Fukatsu T, Nakashima N. Rinsho Byori; 1994 Oct 22; 42(10):1021-8. PubMed ID: 7527871 [Abstract] [Full Text] [Related]
15. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee SD. J Surg Oncol; 2007 Jun 15; 95(8):645-51. PubMed ID: 17530668 [Abstract] [Full Text] [Related]
16. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Hepatology; 1994 Jan 15; 19(1):61-6. PubMed ID: 7506227 [Abstract] [Full Text] [Related]
17. Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions. Taketa K, Sekiya C, Namiki M, Akamatsu K, Ohta Y, Endo Y, Kosaka K. Gastroenterology; 1990 Aug 15; 99(2):508-18. PubMed ID: 1694805 [Abstract] [Full Text] [Related]
18. [Subject diagnostic value of detecting a1pha-fetoprotein variants with a new microspincolumn method in hepatocellular carcinoma]. Xu AF, Wang MC, Sui DM, Yuan YH, Chen G, Lou GQ. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar 15; 21(1):67-9. PubMed ID: 17429541 [Abstract] [Full Text] [Related]
19. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma]. Tamura A, Oita T, Sakizono K, Nakajima T, Kasakura S. Rinsho Byori; 1998 Feb 15; 46(2):158-62. PubMed ID: 9528340 [Abstract] [Full Text] [Related]
20. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Ozer B, Serin E, Yilmaz U, Gümürdülü Y, Saygili OB, Kayaselçuk F, Boyacioğlu S. Turk J Gastroenterol; 2003 Jun 15; 14(2):85-90. PubMed ID: 14614632 [Abstract] [Full Text] [Related] Page: [Next] [New Search]